Aviva Strategies (fka Mgb Consulting) is a registered federal lobbying firm. For Q3 2026 it reported $145K across 5 client reports and lists 1 lobbyist across its filings. Issues include Health Issues and Medical/Disease Research/Clinical Labs.
| Client | Reported | Issues |
|---|---|---|
| ENDEAVOR BIOMEDICINES | $51K | Health Issues |
| ELEMENT BIOSCIENCES | $44K | Health Issues, Medical/Disease Research/Clinical Labs |
| ACT FOR ULTRA RARE | $38K | Health Issues |
| ARPA-H GO | $12K | Health Issues |
| TAYSHA GENE THERAPIES | $0 |
| Year | Reported | Clients |
|---|---|---|
| 2026 | $425K | 8 |
| 2025 | $494K | 6 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.